Lajapsa S.A.
⚠️ Moderate Risk
FEI: 3002593862 • Guatemala, Guatemala • GUATEMALA
FEI Number
3002593862
Location
Guatemala, Guatemala
Country
GUATEMALAAddress
3a Calle a 1-66 z. 10, , Guatemala, Guatemala, Guatemala
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
PESTICIDE
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain a pesticide chemical residue, which causes the article to be adulterated within the meaning of section 402(a)(2)(B) of the FD&C Act. Bears or contains:
Refusal History
Frequently Asked Questions
What is Lajapsa S.A.'s FDA import refusal history?
Lajapsa S.A. (FEI: 3002593862) has 2 FDA import refusal record(s) in our database, spanning from 7/8/2003 to 3/29/2005.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Lajapsa S.A.'s FEI number is 3002593862.
What types of violations has Lajapsa S.A. received?
Lajapsa S.A. has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Lajapsa S.A. come from?
All FDA import refusal data for Lajapsa S.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.